STAGE IA2 LUNG CANCER AJCC V8
Clinical trials for STAGE IA2 LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IA2 LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IA2 LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a single drug stop lung cancer before it starts?
Prevention CompletedThis study tested whether the immunotherapy drug pembrolizumab can prevent lung cancer from growing in people with early-stage non-small cell lung cancer or high-risk lung nodules. 45 participants received the drug and were monitored for tumor response and survival. The goal was …
Matched conditions: STAGE IA2 LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated May 19, 2026 11:48 UTC
-
Hidden heart risks: tiny implant reveals Radiation's toll on cancer patients
Knowledge-focused CompletedThis study looked at heart changes in 24 people receiving radiation or chemo-radiation for lung or esophageal cancer. Participants had a small heart monitor implanted to track any heart problems that might otherwise go unnoticed. The goal was to better understand how cancer treat…
Matched conditions: STAGE IA2 LUNG CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC